ACTIVE

Ap. Pharmamax

Financial year 2025 · Closed on 31/12/2025

Net result130,7 k €-55,0 %over 1 year
Gross margin184 k €-47,9 %over 1 year
Equity377,7 k €+7,9 %over 1 year
Workforce0,0 ETP-100,0 %over 1 year

Identity

Source · BCE/KBO

Ap. Pharmamax is a Private company with limited liability incorporated in 1988. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Boom.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0434.458.941
Incorporation
04/06/1988
Legal form
Private company with limited liability
Registered office
Peter Benoitstraat 46
2850 Boom · FlandreSee on map
Contributed capital
25 000,00 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 15 financial years

20252024202320222021
Income statement
Gross margin184 k €353,4 k €368,4 k €361,2 k €320 k €
EBITDA182,2 k €323,9 k €346,5 k €328,3 k €286,8 k €
Operating result171,7 k €312 k €332,2 k €320,1 k €272,4 k €
Net result130,7 k €290,2 k €323 k €222,4 k €188,3 k €
Balance sheet
Equity377,7 k €350 k €349,8 k €326,8 k €104,4 k €
Total assets1,1 M €1 M €851,8 k €572,9 k €455,5 k €
Cash549,6 k €355,5 k €343,5 k €232,5 k €106,9 k €
Debts707,5 k €660,1 k €415,4 k €246,1 k €350,4 k €
Other
Workforce0,0 ETP0,8 ETP0,8 ETP0,0 ETP0,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Pharmagrex0635.846.678Represented by Martine Bleys
Directorsince 01/09/2015Manager01/09/2015 → 2018 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Pharmagrex NVRepresented by Martine Bleys
Bestuurder01/09/2015 → 2021 accounts
Filip Baute
Manager20/11/2013 → 2014 accounts
Steven Meuleman
Manager01/07/2008 → 2014 accounts
Mari-Rose Vogelaers
Manager2007 accounts

Other companies at this address

Peter Benoitstraat 46 2850 Boom
CompanyCBE no.
Pharmagrex● Active
0635.846.678

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/09/202604/09/202517/12/202418/12/202329/09/202217/08/2021
General meeting30/06/202630/06/202530/06/202430/06/202303/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202629/09/2026DutchPDF
Abridged model31/12/202430/06/202504/09/2025DutchPDF
Abridged model31/12/202330/06/202417/12/2024DutchPDF
Abridged model31/12/202230/06/202318/12/2023DutchPDF
Abridged model31/12/202103/06/202229/09/2022DutchPDF
Abridged model31/12/202004/06/202117/08/2021DutchPDF
Abridged model31/12/201905/06/202029/07/2020DutchPDF
Abridged model31/12/201807/06/201919/07/2019DutchPDF
Abridged model31/12/201701/06/201826/07/2018DutchPDF
Abridged model31/12/201602/06/201708/08/2017DutchPDF
Abridged model31/12/201503/06/201622/08/2016DutchPDF
Abridged model31/12/201405/06/201524/07/2015DutchPDF
Abridged model31/12/201306/06/201430/07/2014DutchPDF
Abridged model31/12/201207/06/201322/07/2013DutchPDF
Abridged model31/12/201101/06/201217/07/2012DutchPDF
Abridged model31/12/201003/06/201121/07/2011DutchPDF
Abridged model30/06/201024/09/201018/01/2011DutchPDF
Abridged model30/06/200925/09/200905/02/2010DutchPDF
Abridged model30/06/200826/09/200823/12/2008DutchPDF
Abridged model31/12/200730/05/200815/07/2008DutchPDF
Abridged model31/12/200625/05/200729/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Pharmagrex0635.846.678Represented by Martine Bleys
Directorsince 01/09/2015Manager01/09/2015 → 2018 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Pharmagrex NVRepresented by Martine Bleys
Bestuurder01/09/2015 → 2021 accounts
Filip Baute
Manager20/11/2013 → 2014 accounts
Steven Meuleman
Manager01/07/2008 → 2014 accounts
Mari-Rose Vogelaers
Manager2007 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates13/10/2015
    Naamwijziging — Statutenwijzigingen — Ontslag van de statutaire :
    PDF
  • Mandates03/12/2013
    benoeming statutair zaakvoerder
    PDF
  • Mandates01/10/2010
    ONTSLAGEN - BENOEMINGEN - BOEKJAAR
    PDF
  • Mandates20/06/2008
    ONTSLAGEN - BENOEMINGEN - BOEKJAAR
    PDF
  • Capital / shares19/09/2007
    Buitengewone algemene vergadering — Kapitaalvermindering-
    PDF
  • Capital / shares16/10/2006
    | KAPITAALVERHOGING - OMZETTING VAN HET KAPITAAL IN EURO STATUTENWIJZIGING
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings15 filings
Mandates
Pharmagrex
Pharmagrex NV
Filip Baute
Steven Meuleman
Mari-Rose Vogelaers
198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026
Ap. Pharmamax
Peter Benoitstraat 46, 2850 Boom
DirectorManager
Bestuurder
Manager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Peter Benoitstraat 46, 2850 BoomCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00547893

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Ap. PharmamaxCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00547893
Pharmamax BVBA
accounts 2021
Accounts 2021 · 2022-20439554

Events

  1. 2025
    Annual accounts 2025130,7 k €↓
  2. 2024
    Annual accounts 2024290,2 k €↓
  3. 2023
    Annual accounts 2023323 k €↑
  4. 2022
    Annual accounts 2022222,4 k €↑
  5. 2022
    Name changeAp. Pharmamax
  6. 2021
    Annual accounts 2021188,3 k €↑
  7. 2014
    Annual accounts 2014-27,9 k €↑
  8. 2013
    Annual accounts 2013-156,5 k €↓
  9. 2012
    Annual accounts 2012-56,2 k €↑
  10. 2011
    Annual accounts 2011-64,3 k €↓
  11. 2010
    Annual accounts 201030,5 k €↑
  12. 2010
    Annual accounts 2010-5,4 k €↑
  13. 2009
    Annual accounts 2009-7,9 k €↓
  14. 2008
    Annual accounts 20086,7 k €↓
  15. 2007
    Annual accounts 200715,9 k €↑
  16. 2006
    Annual accounts 2006-22,2 k €
  17. 04/06/1988
    IncorporationPrivate company with limited liability